AmphiStar unveils sustainable biosurfactant platform

AmphiStar has launched AmphiNova, its proprietary biosurfactant platform. The platform contains over 80 versatile biosurfactants sourced from biological waste byproducts and side streams, providing an alternative to synthetic surfactants and those that rely on virgin crops.

The Belgian biosurfactants manufacturer states that AmphiNova, which acts as a molecule catalog, is available for collaboration across various personal care applications with partners developing novel surfactants and are focusing on sustainability.

According to AmphiStar, each molecule featured in the platform is selected with precision and optimized to enhance its specific characteristics. In doing so, the platform fine-tunes the core functions of the surfactants to its intended application.

The launch also enhances AmphiStar’s potential collaborations with formulators by broadening the scope of access to AmphiStar’s biosurfactant molecules. It allows formulators to investigate a wider range of molecules with varying functionalities and traits.

“AmphiNova is a game changer for us because we now have a ready-made portfolio of molecules as a starting point for meeting a diverse range of industry needs. With further tailoring, we can meet the exact needs of an individual client or application to ensure that unprecedented sustainability doesn’t compromise functionality,” says Pierre-Franck Valentin, CEO at AmphiStar.

Sophie Roelants, AmphiStar COO adds that AmphiNova offers “not only the variety of new sustainable ingredients the surfactant market is looking for, it encompasses a proprietary Synbio technology platform that allows AmphiStar to design and deliver designer surfactants to market.”

She calls this method “key” to make biosurfactants mainstream.

Launching to marketThe platform fine-tunes the core functions of the surfactants to its intended application.

AmphiStar is undertaking the launch-to-market with a dual approach. The first component of its approach is a pipeline of partners across various fields, aiming for a robust market entry with strong technical and commercial alignment.

By employing targeted partnerships and establishing joint development agreements, the company aims to place its energy in specific markets or regions, optimizing co-development outcomes.

The second pillar of the approach is more direct, as the company will launch selected AmphiNova molecules directly to market in 2026. The releases will expand AmphiStar’s current portfolio of personal and home care biosurfactants, made up of four products launched in 2024.

The company underlines its sustainability endeavors, stating that a life cycle assessment concluded in March 2025 found that the company’s biosurfactants demonstrated superior sustainability when compared to traditional alternatives.

The assessment found that AmphiStar’s biosurfactants demonstrated a four-fold reduction in CO2 emissions, an 18-fold reduction in water deprivation, a 5.5-fold lower impact on human health, and a 15-fold lower overall environmental impact.